At the end of summer we told you all about a new initiative of the National Brain Tumor Society called the Clinical Trial Endpoints Initiative. At the time we were just getting back from an extremely fruitful meeting with the U.S. Food & Drug Administration (FDA), which set the stage for two upcoming workshops with [...]
The Society for Neuro-Oncology (SNO), the preeminent trade organization for those working in the brain tumor arena, seeks to advance the field through research and education. SNO hosts an annual multi-day meeting that is ‘must-go’ for brain cancer researchers, clinicians, surgeons, patient advocacy organizations, and biopharma industry executives
When The Cancer Genome Atlas (TCGA) launched in 2006, it was a huge moment for cancer research. The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) had come together to deliver researchers a better understanding of the molecular basis of cancer through the application of genome analysis and sequencing technologies.